首页> 外文期刊>American journal of applied sciences >Association of Oral Contraceptives and Abnormal Pap Smear | Science Publications
【24h】

Association of Oral Contraceptives and Abnormal Pap Smear | Science Publications

机译:口服避孕药与异常子宫颈抹片检查的关联科学出版物

获取原文
           

摘要

> To assess the hypothesis that combined Oral Contraceptive (OCs) increase the risk of cervical neoplasia, we conducted a multicenter Case-Control study in Mashhad, the capital of Khorasan province. Seventy-eight women with moderate to severe dysplasia at Pap smear as case group and one hundred fifty nine women with normal Pap smear were selected as the control group for evaluation. The both case and control groups were matched by age, parity and socioeconomic status. All of the women in this study were single partner as husband and no smoker. 30 percent of cases and 64.8 percent of controls were used OCs. The duration of OCs use was the same in both. The odds ratio for OCs consumption was 0.2 with 95% confidence interval 0.11-0.4 in Logistic regression analysis. In contrast to some other studies, our findings showed an association between OCs and cervical dysplasia and there was a protective effect of OCs for cervical dysplasia.
机译: >为了评估联合口服避孕药(OCs)会增加子宫颈癌风险的假说,我们在霍拉桑省省会Mashhad进行了多中心病例对照研究。选取巴氏涂片检查为中度至重度不典型增生的七十八名妇女作为病例组,巴氏涂片检查为正常的一百五十九名妇女作为对照组。病例组和对照组均按年龄,性别和社会经济状况进行匹配。这项研究中的所有妇女都是丈夫的单身伴侣,没有吸烟者。 30%的病例和64.8%的对照使用过OC。两者使用OC的持续时间相同。在Logistic回归分析中,OC消耗的比值比为0.2,95%置信区间为0.11-0.4。与其他一些研究相比,我们的研究结果表明OC与宫颈发育异常之间存在关联,并且OC对宫颈发育异常具有保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号